- |||||||||| Phase classification, Enrollment change: Positive Airway Pressure for the Treatment of Asthma (clinicaltrials.gov) - May 17, 2017
P=N/A, N=31, Completed, Completed --> Active, not recruiting | Trial primary completion date: Dec 2009 --> Dec 2025 Phase classification: P1/2 --> P=N/A | N=23 --> 31
- |||||||||| Enrollment closed, Trial primary completion date, HEOR, Cost effectiveness: REST: MRA Therapy Versus CPAP Therapy in Moderate OSAS (clinicaltrials.gov) - May 8, 2017
P=N/A, N=86, Active, not recruiting, N=700 --> 0 | Suspended --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Nov 2017
- |||||||||| Enrollment change, Trial termination, Trial primary completion date, Compliance: Impact of Interface With/Without Oral Appliance of Sleep Apnea Treatment (clinicaltrials.gov) - May 5, 2017
P=N/A, N=15, Terminated, Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Nov 2017 N=35 --> 15 | Recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Jan 2017; Inability to further include additional patients
- |||||||||| Enrollment closed, Trial primary completion date: Unrecognised Obstructive Sleep Apnea Study (clinicaltrials.gov) - May 5, 2017
P=N/A, N=400, Active, not recruiting, N=35 --> 15 | Recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Jan 2017; Inability to further include additional patients Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Dec 2018
- |||||||||| Trial completion, Enrollment change, Surgery: Semi-up Right Position Study (clinicaltrials.gov) - May 4, 2017
P=N/A, N=164, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed | N=56 --> 164
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Oxygen Supplementation Study in Obstructive Sleep Apnea (OSA) Patients (clinicaltrials.gov) - May 4, 2017
P=N/A, N=196, Completed, Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Feb 2017 Active, not recruiting --> Completed | N=156 --> 196 | Trial primary completion date: Dec 2016 --> Apr 2017
- |||||||||| Biomarker, Trial completion, Enrollment change, Trial primary completion date: BOSA: Biomarkers for Obstructive Sleep Apnea (clinicaltrials.gov) - Apr 18, 2017
P=N/A, N=181, Completed, Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Nov 2016 Active, not recruiting --> Completed | N=40 --> 181 | Trial primary completion date: Oct 2016 --> Feb 2015
- |||||||||| Trial termination: Neurocognitive Function in Snoring Children (clinicaltrials.gov) - Apr 10, 2017
P=N/A, N=40, Terminated, N=20 --> 2 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Mar 2017; Recruitment rates too low Completed --> Terminated; PI left the university
- |||||||||| Egrifta (tesamorelin acetate) / Theratechnologies, Massachusetts General Hospital
Enrollment change, Trial withdrawal: Egrifta Replacement and Sleep Disordered Breathing (clinicaltrials.gov) - Mar 3, 2017 P=N/A, N=0, Withdrawn, N=60 --> 10 | Trial primary completion date: Oct 2014 --> Jan 2017 N=20 --> 0 | Suspended --> Withdrawn
- |||||||||| Trial completion, Enrollment change: Autonomic Function in Obstructive Sleep Apnea (clinicaltrials.gov) - Feb 24, 2017
P=N/A, N=70, Completed, N=20 --> 0 | Suspended --> Withdrawn Active, not recruiting --> Completed | N=90 --> 70
- |||||||||| Trial completion, Trial primary completion date: Sleep and Stent Study: a Multicentre, Prospective Study (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=1815, Completed, Active, not recruiting --> Completed | N=90 --> 70 Active, not recruiting --> Completed | Trial primary completion date: Sep 2018 --> Sep 2015
- |||||||||| Trial completion, Enrollment change, Trial primary completion date, Surgery: PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular Function (clinicaltrials.gov) - Feb 3, 2017
P=N/A, N=17, Completed, Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | N=69 --> 17 | Trial primary completion date: Jan 2018 --> Sep 2016
- |||||||||| Trial completion, Phase classification, Trial primary completion date: Renal Denervation in Patients With Resistant Hypertension and Obstructive Sleep Apnea (clinicaltrials.gov) - Jan 26, 2017
P=N/A, N=60, Completed, Recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2015 Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | Trial primary completion date: Mar 2015 --> Feb 2016
- |||||||||| Enrollment open, Phase classification, HEOR, Cost effectiveness: Home Nasal Pressure for Sleep Apnea Management in Primary Case (clinicaltrials.gov) - Jan 24, 2017
P=N/A, N=280, Recruiting, Recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jun 2016 Not yet recruiting --> Recruiting | Phase classification: P2 --> PN/A
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: Holter: Electrocardiography Data Analysis in Sleep Disorders (clinicaltrials.gov) - Jan 10, 2017
P=N/A, N=120, Active, not recruiting, N=175 --> 0 | Terminated --> Withdrawn Recruiting --> Active, not recruiting | N=300 --> 120 | Trial primary completion date: Mar 2015 --> Mar 2018
|